Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 191

The DOI matches its Crossref record.

Antihypertensive Therapy with MK 4211: Angiotensin II-Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade

Biollaz, Jerôme, Brunner, Hans R., Gavras, Irène, Waeber, Bernard, Gavras, Haralambos·1982·Journal of Cardiovascular Pharmacology

Abstract

Nineteen hypertensive patients were treated with increasing doses of the new angiotensin-converting enzyme inhibitor MK 421. Twenty milligrams orally reduced blood pressure from 180/112 ± 6.8/3.6 (mean ± SEM) to 160/100 ± 6.5/3.3 mm Hg (p < 0.005) while heart rate increased from 75 ± 2 to 87 ± 3 beats/min (p < 0.005). Plasma converting enzyme activity was still markedly reduced 24h following 2.5. 5, 10, or 20 mg MK 421 p.o. (p < 0.001). In nine patients treated with 20 mg b.i.d. for up to 10 months, blood pressure was controlled, with the association of hydrochlorothiazide 50 mg q.d. in five. However, 12 to 16 h following the preceding drug administration, plasma angiotensin II and aldosterone were back to base-line levels. Analysis of plasma angiotensin II-renin relationships strongly suggests that converting enzyme blockade is not complete even 4 h after 20 mg MK 421 and starts to wear off already at 12 h. Thus, MK 421 20 mg taken orally twice daily, effectively reduces blood pressure, but does not constantly suppress plasma angiotensin II and aldosterone. Whether its long duration of action makes once daily administration possible has not yet been established.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00005344-198211000-00014

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 191

Metadata

Authors
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H.
Venue
Journal of Cardiovascular Pharmacology
Published
1982-11
Volume
4
Issue
6
Pages
966-972
ISSN
0160-2446 (ISSN-L)
OpenAlex
W4320300920
Cited by
191
References
0
FWCI
7.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antihypertensive Therapy with MK 4211: Angiotensin II-Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade. https://app.cochat.ai/papers/10.1097/00005344-198211000-00014
The paper
Biollaz, J., Brunner, H. R., Gavras, I., Waeber, B., & Gavras, H. (1982). Antihypertensive Therapy with MK 4211: Angiotensin II-Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/00005344-198211000-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.